1. Home
  2. KLXE vs KPTI Comparison

KLXE vs KPTI Comparison

Compare KLXE & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • KPTI
  • Stock Information
  • Founded
  • KLXE 2018
  • KPTI 2008
  • Country
  • KLXE United States
  • KPTI United States
  • Employees
  • KLXE N/A
  • KPTI N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • KPTI Health Care
  • Exchange
  • KLXE Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • KLXE 89.2M
  • KPTI 81.1M
  • IPO Year
  • KLXE N/A
  • KPTI 2013
  • Fundamental
  • Price
  • KLXE $4.80
  • KPTI $0.62
  • Analyst Decision
  • KLXE Hold
  • KPTI Strong Buy
  • Analyst Count
  • KLXE 1
  • KPTI 4
  • Target Price
  • KLXE $4.50
  • KPTI $5.00
  • AVG Volume (30 Days)
  • KLXE 191.8K
  • KPTI 679.6K
  • Earning Date
  • KLXE 03-05-2025
  • KPTI 02-27-2025
  • Dividend Yield
  • KLXE N/A
  • KPTI N/A
  • EPS Growth
  • KLXE N/A
  • KPTI N/A
  • EPS
  • KLXE N/A
  • KPTI N/A
  • Revenue
  • KLXE $738,000,000.00
  • KPTI $148,442,000.00
  • Revenue This Year
  • KLXE N/A
  • KPTI $5.47
  • Revenue Next Year
  • KLXE $4.79
  • KPTI $6.33
  • P/E Ratio
  • KLXE N/A
  • KPTI N/A
  • Revenue Growth
  • KLXE N/A
  • KPTI 1.77
  • 52 Week Low
  • KLXE $4.18
  • KPTI $0.58
  • 52 Week High
  • KLXE $9.80
  • KPTI $1.70
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 36.20
  • KPTI 41.95
  • Support Level
  • KLXE $4.51
  • KPTI $0.60
  • Resistance Level
  • KLXE $6.16
  • KPTI $0.69
  • Average True Range (ATR)
  • KLXE 0.43
  • KPTI 0.05
  • MACD
  • KLXE -0.18
  • KPTI -0.00
  • Stochastic Oscillator
  • KLXE 4.75
  • KPTI 18.17

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: